Synthego Stock

synthego.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $415.07MM

Synthego, founded in 2012 by Paul and Michael Dabrowski, is a genome engineering company leveraging machine learning, automation, and gene editing to build platforms for science at scale. Synthego is setting out to accelerate CRISPR research, a genome engineering technique that could help cure genetic diseases or even bring back woolly mammoths from extinction. Synthego is headquartered in Redwood City, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Synthego, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Synthego’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Synthego.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Paul Dabrowski
Co-Founder & Chief Executive Officer
John Tan
Chief Operating Officer & President
Avi Raval
Chief Financial Officer & Chief Business Officer
Robert Deans Ph.D
Chief Scientific Officer

Board Members

Drew Oetting
8VC
Francisco Gimenez Ph.D
8VC
Nathaniel Horwitz
RA Capital Management
Scott Nolan
Founders Fund

Frequently Asked Questions About Synthego’s Stock

plusminus
Can you buy Synthego’s stock?
Synthego is not publicly traded on NYSE or NASDAQ in the U.S. To buy Synthego’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Synthego’s stock?
Yes, you can sell stock of a private company like Synthego. Forge can help you sell your Synthego stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Synthego’s stock price?
Synthego is a privately held company and therefore does not have a public stock price. However, you may access Synthego’s private market stock price with Forge Data.
plusminus
What is Synthego’s stock ticker symbol?
Synthego does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

People in the News: New Appointments at Quantum-Si, Element Biosciences, Synthego, NeoGenomics, More
Synthego raises $100 million for AI-driven gene editing
Synthego, a startup developing a platform for gene editing experiments, has raised an additional $100 million to advance its work.
In Brief This Week: PerkinElmer, Synthego, Rare Genomics Institute, and More
Updated on: May 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.